Medication info

Ibaron Injection (Ibandronic Acid Sodium Hemihydrate)

Prescription medicationInjections정맥
Ingredient · strength
Ibandronate Sodium Monohydrate›3.375mg / 1 prefilled syringe
Manufacturer / importer
한국코러스(주)
Appearance
A colorless, transparent solution in a colorless, transparent prefilled syringe with a single-use needle attached.
Packaging
3.0 mL/prefilled syringe x 1
Approval status
Active

MFDS item code 201901186 · Notified 2019.02.26 · Insurance code 647205431

Summary

Main use
Improvement of osteoporosis in postmenopausal women
Who receives it
Adults
Adult administration
3 mg intravenously every 3 months, infused over a period of 15 - 30 seconds.

Ingredients

Manufacturer
한국코러스(주)

Efficacy & effects

Improvement of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat osteoporosis commonly occurring in postmenopausal women. Osteoporosis is a condition characterized by low bone density, leading to an increased risk of fractures, particularly prevalent in women after menopause. This drug helps strengthen bones and increase bone density to reduce the risk of fractures. Therefore, it is effective for maintaining healthy bones and treating osteoporosis in postmenopausal women.

How it is given

Adult administration

3 mg intravenously every 3 months, infused over a period of 15 - 30 seconds.

Precautions

This medication must be administered exclusively intravenously, as improper injection into the arteries or around the veins can cause tissue damage. It should not be used in patients with known allergies to this drug or its ingredients, or in untreated hypocalcemia patients. This drug is primarily used for the treatment of osteoporosis; clinical trials have shown safety profiles similar to placebo, although some patients may experience varied adverse reactions such as gastrointestinal disturbances, musculoskeletal pain, headache, and rash. In particular, flu-like symptoms such as arthralgia, myalgia, fever, chills, and fatigue may temporarily occur shortly after initial administration, but these are mostly mild and resolve without treatment. Before administering this drug, it is essential to confirm that calcium levels are normal; if there is hypocalcemia, it should be treated first. During treatment, adequate calcium and vitamin D intake is crucial, and supplements should be taken if necessary. Regular monitoring of kidney function and other health conditions is required during the use of this drug. As a bisphosphonate, there is a rare risk of osteonecrosis of the jaw; therefore, thorough oral hygiene should be maintained before and during treatment, and unnecessary dental procedures should be avoided. Additionally, otologic-related side effects such as external auditory canal osteonecrosis have been reported; if there are any abnormal ear symptoms, consult a physician. Severe pain in bones, joints, or muscles may occur after taking this medication; should these symptoms arise, inform healthcare personnel immediately. This medication may cause rare fractures such as atypical femoral fractures; if there is pain in the thigh or groin, an examination should be conducted. When administering intravenously, there is a possibility of hypersensitivity or allergic reactions, so appropriate measures should be in place for emergencies. The safety for pregnant and breastfeeding women has not been established; it is recommended not to use this medication in such cases. This drug is not metabolized in the liver and is mainly excreted by the kidneys, thus precautions should be taken for patients with liver or kidney issues. In case of overdose, careful monitoring of calcium, phosphorus, and magnesium levels is required, and appropriate treatment should be initiated if necessary, knowing that dialysis may not be effective. This drug should not be mixed with other intravenous medications or solutions containing calcium and should only be diluted and administered with normal saline or 5% dextrose solution. Keep this medication out of the reach of children, and dispose of used syringes and needles securely without reusing.

Side effects and when to seek care immediately

Serious side effects

  • Hives
  • severe swelling (edema)
  • anaphylaxis reaction/shock
  • severe allergic reactions
  • Stevens-Johnson syndrome
  • erythema multiforme
  • bullous dermatitis
  • severe skin adverse reactions
  • angioedema
  • facial swelling/edema
Show 13 more
  • high fever accompanied by severe rash
  • blisters
  • skin peeling
  • oral/ocular mucosal pain
  • respiratory distress
  • difficulty breathing
  • asthma exacerbation
  • anaphylaxis
  • severe allergic reactions
  • acute renal failure
  • multiple organ failure
  • death
  • vascular abnormalities

Mild side effects

Gastritis, diarrhea, abdominal pain, dyspepsia, nausea, constipation, musculoskeletal pain, arthralgia, myalgia, flu-like symptoms (including arthralgia, myalgia, fever, chills, fatigue, nausea, loss of appetite, bone pain), fatigue, headache, rash, bone pain, weakness, injection site reactions, low back pain, dizziness, hypothyroidism, peripheral neuropathy, hearing loss, skin peeling, insomnia, anxiety, tinnitus, lipoma, ocular hemorrhage, heart failure, abdominal pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air, and the storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature. Proper storage will help preserve the medication's efficacy for a longer duration.

Appearance and packaging

Appearance

A colorless, transparent solution in a colorless, transparent prefilled syringe with a single-use needle attached.

Package unit

3.0 mL/prefilled syringe x 1

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.